Search for Clinical Trial Results
Pericardial Effusion - 21 Studies Found
Status | Study |
Completed |
Study Name: Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC) Condition: Lung Cancer Date: 2007-01-31 Interventions: Drug: IPI-504 IV Hsp90 inhibitor |
Completed |
Study Name: Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) Condition: Metastatic Non-squamous Non Small Cell Lung Cancer Date: 2009-07-17 Interventions:
|
Recruiting |
Study Name: The Effect of Chest Tubes Using Active Clearance Technology® on the Incidence of Postoperative Atrial Fibrillation Condition:
|
Terminated |
Study Name: Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer Condition:
Date: 2014-05-06 Interventions: |
Active, not recruiting |
Study Name: Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer Condition:
|
Completed |
Study Name: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu Condition:
|
Completed |
Study Name: QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer Condition:
Interventions: |
Completed |
Study Name: Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer Condition: Non Small Cell Lung Cancer Date: 2006-06-29 Interventions:
|
Completed |
Study Name: Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer Condition: Lung Cancer Date: 2007-07-26 Interventions: Drug: Alimta 500 mg/m^2 by vein Once Over 10 Minutes Every 3 Weeks |
Completed |
Study Name: ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment Condition:
Interventions: Drug: ILX-295501 |